Cher­ry Thomas joins Cari­bou as SVP of clin­i­cal de­vel­op­ment; Ar­tax locks in Joseph Lobac­ki as CEO

→ CRISPR genome edit­ing play­er Cari­bou Bio­sciences has ap­point­ed Cher­ry Thomas as SVP of clin­i­cal de­vel­op­ment, a new­ly-cre­at­ed po­si­tion. Thomas …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.